Fujirebio Diagnostics

Fujirebio Diagnostics is a leader in cancer biomarker assays and in vitro diagnostics. Their products support early detection and monitoring of disease, aiding clinicians in making informed treatment decisions.

Content by Fujirebio Diagnostics

Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G ?-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
| 2 min read
Page 1 of 1 - 1 Total Items
Current Magazine Issue Background Image

CURRENT ISSUE - March/2026

When the Unexpected Hits

How Lab Leaders Can Prepare for Safety Crises That Don’t Follow the Script

Lab Manager March 2026 Cover Image